Nurix Therapeutics is a clinical stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted protein degradation medicines, the next frontier in innovative drug design aimed at improving treatment options for patients with cancer and inflammatory diseases. Powered by a fully AI-integrated discovery engine capable of tackling any protein class, and coupled with unparalleled ligase expertise, Nurix’s dedicated team has built a formidable advantage in translating the science of targeted protein degradation into clinical advancements. Nurix aims to establish degrader-based treatments at the forefront of patient care, writing medicine’s next chapter with a new script to outmatch disease.
Position:
We are seeking a Pharmacovigilance Medical Reviewer to support safety activities for investigational products in clinical development. This role is focused on the medical review and evaluation of individual case safety reports (ICSRs), with an emphasis on early-phase and late-phase clinical trials. The ideal candidate will also be poised to support post-marketing pharmacovigilance activities as our pipeline progresses to commercialization. The Medical Reviewer will be responsible for providing medical expertise in the evaluation and reporting of adverse events, ensuring compliance with global pharmacovigilance regulations, and contributing to the safety profile assessment of Nurix’s pharmaceutical products throughout their lifecycles.
Responsibilities:
Education and Experience
Personal Attributes
Nurix Therapeutics, Inc. is committed to protecting and respecting your privacy and personal information, including information collected by Nurix when you apply for a job with Nurix or in the course of your employment with Nurix. By applying for a position at Nurix, you agree to our collection and use of personal information as described in our Privacy Policy (https://www.nurixtx.com/privacy-policy/).